Akso Health Group

NASDAQ:AHG

Financial - Credit Services

Financial Services
$1.36 +2.44%

+$0.03 today

Market cap
$1.16B
Beta
-1.02
P/E (TTM)
-3.1
EPS (TTM)
-$0.40
52W Low $1.07High $2.50

Volume 0.00M

Average 0.12M

AHG Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Akso Health GroupNASDAQ: AHG

Revenue · Q4 FY2025 · quarter ended Mar 2025

Revenue grows, but more slowly than its trailing trend

Q4 FY2025 revenue of $3.92M rose 415.8% year over year, behind the +512.1% change in trailing-twelve-month revenue. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +35.0% a year.

Context

  • Revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 1 analysts of $108.28M (+632.7%) for the fiscal year ending Mar 2026, a step up from the +512.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2025
$3.92M+0.0% QoQ
Last fiscal yearMar 2025
$14.78M+512.1% YoY
LTMMar 2025
$14.78M+512.1% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+415.8%+107.1%-308.7 pp
1 year+512.1%+632.7%+120.6 pp
3-year CAGR+35.0%+65.2%+30.1 pp
5-year CAGR+46.3%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
14.78M USD
Year-over-year change
+512.1%
4-year CAGR
+70.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How AHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +512.1% is the highest of 4, against a peer median of +3.7%.
  • Over three fiscal years its annual growth of +35.0% compares with a peer median of -2.4%.
AHG Competitors
Revenue for AHG and competitors
Company Period LTM YoY 3-year CAGR
MOMOHello Group Inc.LTM Mar 2026CN¥10.23B CNY-2.8%-6.6%
ZKHZKH Group LimitedLTM Mar 2026CN¥9.17B CNY+3.7%+2.6%
JMIAJumia Technologies AGLTM Mar 2026$203.19M USD+31.2%-2.4%
AHGAkso Health GroupLTM Mar 2025$14.78M USD+512.1%+35.0%
Peer median (excluding AHG) —+3.7%-2.4%

Competitors are the stored peer set for AHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Mar 2021
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
Revenue1.75M6M13.18M2.41M14.78M
Cost of Revenue544.57K5.39M11.91M2.29M15.06M
Gross Profit1.21M605.13K1.27M122.13K(281.53K)
Gross Margin69.0%10.1%9.6%5.1%-1.9%
Research & Development441.41K421.19K000
Selling, General & Admin2.09M3.06M15.54M8.76M3.64M
Operating Expenses28.36M3.87M15.54M8.76M166.02M
Depreciation & Amortization15.16K18.39K18.39K8.64M2.15M
EBITDA(28.9M)(3.19M)(14.27M)(8.64M)(1.77M)
EBITDA Margin-1646.8%-53.1%-108.2%-357.8%-12.0%
Operating Income(27.15M)(3.26M)(14.27M)(8.64M)(166.3M)
Operating Margin-1547.1%-54.3%-108.2%-357.8%-1125.4%
Interest Income00000
Interest Expense2.15M804.14K000
Other Income / Expenses23.34M(747.82K)1.2M(453.75K)34.07K
Income Before Tax(3.81M)(4.01M)(13.07M)(9.09M)(166.27M)
Pre-Tax Margin-217.1%-66.8%-99.1%-376.6%-1125.1%
Income Tax Expense482.98K92.82K17.55K24.99K(30.8M)
Net Income(34.83M)(16.85M)(1.36M)(9.46M)(134.98M)
Net Margin-1984.5%-280.8%-10.3%-391.8%-913.4%
EPS (Basic)(0.26)(2.55)(0.06)(0.45)(0.48)
EPS (Diluted)(0.27)(2.55)(0.06)(0.39)(0.48)
Weighted Avg Shares5.43M6.62M7.62M20.81M285.1M
Weighted Avg Shares (Diluted)5.43M6.62M7.62M23.83M285.1M

Akso Health Group

NASDAQ:AHG

Intrinsic Alpha fair value

Locked

Current Price

$1.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.